RTN1 mediates progression of kidney disease by inducing ER stress

Nature Communications

Volumn 6, Issue , 2015, Pages

  Fan, Ying ^a,b   Xiao, Wenzhen ^a,b   Li, Zhengzhe ^a   Li, Xuezhu ^a   Chuang, Peter Y ^a   Jim, Belinda ^c   Zhang, Weijia ^a   Wei, Chengguo ^a   Wang, Niansong ^b   Jia, Weiping ^b   Xiong, Huabao ^a   Lee, Kyung ^a   He, John C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; PROTEIN; REACTIVE OXYGEN METABOLITE; RTN1 PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN; PERK KINASE; PROTEIN KINASE R; RTN1 PROTEIN, HUMAN; RTN1 PROTEIN, MOUSE;

APOPTOSIS; BIOMARKER; CELL ORGANELLE; CORRELATION; DIABETES; DISEASE PREVALENCE; GENE EXPRESSION; IDENTIFICATION METHOD; MUTATION; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; UPREGULATION; URETER OBSTRUCTION; ADULT; ANIMAL; COMPLICATION; DIABETIC NEPHROPATHIES; DISEASE COURSE; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GENE SILENCING; GENE TARGETING; GENETICS; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS;

ADULT; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EIF-2 KINASE; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE KNOCK-IN TECHNIQUES; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; MICE; MIDDLE AGED; NERVE TISSUE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

EID: 84938537691     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8841     Document Type: Article

References (44)

1. Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038-2047 (2007).
2. Lewis, E. J., Hunsicker, L. G., Bain, R. P. & Rohde, R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329, 1456-1462 (1993).
3. Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869 (2001).
4. de Zeeuw, D. Unmet need in renal protection-do we need a more comprehensive approach? Contrib. Nephrol. 171, 157-160 (2011).
5. Masliah, E. et al. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice. Neuroscience 169, 488-494 (2010).
6. Heath, J. E. et al. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology 30, 574-579 (2010).
7. Abdesselem, H., Shypitsyna, A., Solis, G. P., Bodrikov, V. & Stuermer, C. A. No Nogo66- and NgR-mediated inhibition of regenerating axons in the zebrafish optic nerve. J. Neurosci. 29, 15489-15498 (2009).
8. Xiang, R. & Zhao, S. RTN3 inducing apoptosis is modulated by an adhesion protein CRELD1. Mol. Cell. Biochem. 331, 225-230 (2009).
9. Liu, Y. et al. Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J. Biol. Chem. 283, 6561-6571 (2008).
10. Iwahashi, J. & Hamada, N. Human reticulon 1-A and 1-B interact with a medium chain of the AP-2 adaptor complex. Cell. Mol. Biol. (Noisy-le-grand) 49 Online Pub OL467-OL471 (2003).
11. Fazi, B. et al. Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors. Oncogene 28, 3814-3824 (2009).
12. Di Sano, F., Fazi, B., Tufi, R., Nardacci, R. & Piacentini, M. Reticulon-1C acts as a molecular switch between endoplasmic reticulum stress and genotoxic cell death pathway in human neuroblastoma cells. J. Neurochem. 102, 345-353 (2007).
13. Lu, T. C., He, J. C. & Klotman, P. Animal models of HIV-associated nephropathy. Curr. Opin. Nephrol. Hypertens. 15, 233-237 (2006).
14. Ikee, R. et al. Involvement of transglutaminase-2 in pathological changes in renal disease. Nephron. Clin. Pract. 105, c139-c146 (2007).
15. Bussolati, B., Collino, F. & Camussi, G. CD133+ cells as a therapeutic target for kidney diseases. Expert Opin. Ther. Targets 16, 157-165 (2012).
16. Woroniecka, K. I. et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 60, 2354-2369 (2011).
17. Lindenmeyer, M. T. et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J. Am. Soc. Nephrol. 19, 2225-2236 (2008).
18. GrandPre, T., Nakamura, F., Vartanian, T. & Strittmatter, S. M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439-444 (2000).
19. Chiurchiu, V., Maccarrone, M. & Orlacchio, A. The role of reticulons in neurodegenerative diseases. Neuromolecular Med. 16, 3-15 (2014).
20. Premsrirut, P. K. et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145-158 (2011).
21. He, W. et al. Reticulon family members modulate BACE1 activity and amyloidbeta peptide generation. Nat. Med. 10, 959-965 (2004).
22. Montenegro, G. et al. Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J. Clin. Invest. 122, 538-544 (2012).
23. Cunard, R. & Sharma, K. The endoplasmic reticulum stress response and diabetic kidney disease. Am. J. Physiol. Renal. Physiol. 300, F1054-F1061 (2011).
24. Morse, E. et al. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am. J. Physiol. Renal. Physiol. 299, F965-F972 (2010).
25. Kimura, K., Jin, H., Ogawa, M. & Aoe, T. Dysfunction of the ER chaperone BiP accelerates the renal tubular injury. Biochem. Biophys. Res. Commun. 366, 1048-1053 (2008).
26. Liu, G. et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun. 370, 651-656 (2008).
27. Wu, X., He, Y., Jing, Y., Li, K. & Zhang, J. Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. OMICS 14, 61-73 (2010).
28. Cybulsky, A. V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int. 77, 187-193 (2010).
29. Lee, E. K. et al. Activation of AMP-activated protein kinase inhibits albumininduced endoplasmic reticulum stress and apoptosis through inhibition of reactive oxygen species. Nephron Exp. Nephrol. 121, e38-e48 (2012).
30. Wu, J. et al. Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am. J. Pathol. 176, 2163-2176 (2010).
31. Inagi, R. et al. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int. 68, 2639-2650 (2005).
32. Nakatani, Y. et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280, 847-851 (2005).
33. Ozawa, K. et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 54, 657-663 (2005).
34. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140 (2006).
35. Luo, Z. F. et al. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicol. Appl. Pharmacol. 246, 49-57 (2010).
36. Ratnam, K. K. et al. Role of the retinoic acid receptor-alpha in HIV-associated nephropathy. Kidney Int. 79, 624-634 (2011).
37. Jin, Y. et al. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat. Med. 18, 580-588 (2012).
38. Mallipattu, S. K. et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int. 83, 626-634 (2013).
39. Zheng, F. et al. Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int. 70, 507-514 (2006).
40. Rosenstiel, P. E. et al. HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int. 74, 1049-1058 (2008).
41. Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630-638 (2002).
42. Chuang, P. Y., Yu, Q., Fang, W., Uribarri, J. & He, J. C. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int. 72, 965-976 (2007).
43. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
44. He, J. C. et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J. Clin. Invest. 114, 643-651 (2004).